<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 10 Apr 2026 06:19:12 -0400--><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel>
        <title>ProMIS Neurosciences, Inc. (PMN) In The News</title>
        <link>https://www.promisneurosciences.com/news-media/in-the-news/rss</link>
        <language>en-us</language>
        <description></description>

                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/promisneurosciences/files/theme/images/logo-sm.png</url>
                <title>ProMIS Neurosciences, Inc. Logo</title>
                <link>https://www.promisneurosciences.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[The ALS Curveball, Part II]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/_5ac31461ce058bc747d5df569c69fcff/promisneurosciences/db/926/8763/pdf/The+ALS+Curveball+Ch2.pdf</link>
                <pubDate>Wed, 05 Oct 22 00:00:00 -0400</pubDate>
                <guid>https://d1io3yog0oux5.cloudfront.net/_5ac31461ce058bc747d5df569c69fcff/promisneurosciences/db/926/8763/pdf/The+ALS+Curveball+Ch2.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[The ALS Curveball, Part I]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/_5ac31461ce058bc747d5df569c69fcff/promisneurosciences/db/926/8762/pdf/ALS+Curveball+Ch1.pdf</link>
                <pubDate>Wed, 05 Oct 22 00:00:00 -0400</pubDate>
                <guid>https://d1io3yog0oux5.cloudfront.net/_5ac31461ce058bc747d5df569c69fcff/promisneurosciences/db/926/8762/pdf/ALS+Curveball+Ch1.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[New Collaborative Research Grant will Support the Development of a Vaccine for Misfolded Protein Diseases]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.centreforbrainhealth.ca/news/new-collaborative-research-grant-will-support-the-development-of-a-vaccine-for-misfolded-protein-diseases/</link>
                <pubDate>Tue, 02 Aug 22 00:00:00 -0400</pubDate>
                <guid>https://www.centreforbrainhealth.ca/news/new-collaborative-research-grant-will-support-the-development-of-a-vaccine-for-misfolded-protein-diseases/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[A Tale of Tangles We Weave, Chapter 4]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.prdistribution.com/news/a-tale-of-tangles-chapter-4-evolution/9221004</link>
                <pubDate>Mon, 18 Jul 22 00:00:00 -0400</pubDate>
                <guid>https://www.prdistribution.com/news/a-tale-of-tangles-chapter-4-evolution/9221004</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ProMIS rings Nasdaq closing bell, July 13, 2022]]></title>
                <description><![CDATA[]]></description>
                <link>https://jwp.io/s/Z5vZcpQf</link>
                <pubDate>Thu, 14 Jul 22 00:00:00 -0400</pubDate>
                <guid>https://jwp.io/s/Z5vZcpQf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[A Tale Of Tangles We Weave]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.benzinga.com/general/biotech/22/03/26184820/a-tale-of-tangles-we-weave</link>
                <pubDate>Thu, 17 Mar 22 00:00:00 -0400</pubDate>
                <guid>https://www.benzinga.com/general/biotech/22/03/26184820/a-tale-of-tangles-we-weave</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Stimulating the Next Generation of AD Treatment]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/promisneurosciences/files/pages/promisneurosciences/db/926/content/2022_01_11_PMN.TO_Panel_Stimulating_The_Next_Generation_of_AD_Therapies.pdf</link>
                <pubDate>Tue, 11 Jan 22 00:00:00 -0500</pubDate>
                <guid>https://d1io3yog0oux5.cloudfront.net/promisneurosciences/files/pages/promisneurosciences/db/926/content/2022_01_11_PMN.TO_Panel_Stimulating_The_Next_Generation_of_AD_Therapies.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Funding boost expands MND research in our region]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.miragenews.com/funding-boost-expands-mnd-research-in-our-region-645228/</link>
                <pubDate>Tue, 05 Oct 21 00:00:00 -0400</pubDate>
                <guid>https://www.miragenews.com/funding-boost-expands-mnd-research-in-our-region-645228/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Aducanumab edges closer to Potential Approval: Next up, the Advisory Committee meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://pharmaboardroom.com/articles/aducanumab-edges-closer-to-potential-approval-next-up-the-advisory-committee-meeting/</link>
                <pubDate>Wed, 04 Nov 20 00:00:00 -0500</pubDate>
                <guid>https://pharmaboardroom.com/articles/aducanumab-edges-closer-to-potential-approval-next-up-the-advisory-committee-meeting/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Aducanumab: On the Regulatory Home Stretch in the USA]]></title>
                <description><![CDATA[]]></description>
                <link>https://pharmaboardroom.com/articles/aducanumab-on-the-regulatory-home-stretch/</link>
                <pubDate>Wed, 23 Sep 20 00:00:00 -0400</pubDate>
                <guid>https://pharmaboardroom.com/articles/aducanumab-on-the-regulatory-home-stretch/</guid>
                                                                            </item>
            </channel>
</rss>